PROM1 and neoplasm: In an independent cohort of 300 GC primary cases (GSE62254), the correlative analyses with CD133 signature levels were performed for (a) Lauren classification, (b) tumor stages, (c) molecular subtypes, and (4) MLH1-IHC positivity.